Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
Chang, T.; Ho, H.-L.; Hsu, S.-J.; Chang, C.-C.; Tsai, M.-H.; Huo, T.-I.; Huang, H.-C.; Lee, F.-Y.; Hou, M.-C.; Lee, S.-D. Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. Int. J. Mol. Sci. 2019, 20, 4161. https://doi.org/10.3390/ijms20174161
Chang T, Ho H-L, Hsu S-J, Chang C-C, Tsai M-H, Huo T-I, Huang H-C, Lee F-Y, Hou M-C, Lee S-D. Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. International Journal of Molecular Sciences. 2019; 20(17):4161. https://doi.org/10.3390/ijms20174161
Chicago/Turabian StyleChang, Ting; Ho, Hsin-Ling; Hsu, Shao-Jung; Chang, Ching-Chih; Tsai, Ming-Hung; Huo, Teh-Ia; Huang, Hui-Chun; Lee, Fa-Yauh; Hou, Ming-Chih; Lee, Shou-Dong. 2019. "Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats" Int. J. Mol. Sci. 20, no. 17: 4161. https://doi.org/10.3390/ijms20174161